{"data":{"id":"us/37-cfr-appendix-d-to-subpart-g-of-part-1","jurisdiction":"us","citation":"37 CFR Appendix D to Subpart G of Part 1","heading":"Appendix D to Subpart G of Part 1—List of Modified and Unusual Amino Acids","body":"Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).\nSymbol Meaning\nAad 2-Aminoadipic acid.\nbAad 3-Aminoadipic acid.\nbAla beta-Alanine, beta-Aminopropionic acid.\nAbu 2-Aminobutyric acid.\n4Abu 4-Aminobutyric acid, piperidinic acid.\nAcp 6-Aminocaproic acid.\nAhe 2-Aminoheptanoic acid.\nAib 2-Aminoisobutyric acid.\nbAib 3-Aminoisobutyric acid.\nApm 2-Aminopimelic acid.\nDbu 2,4 Diaminobutyric acid.\nDes Desmosine.\nDpm 2,2′-Diaminopimelic acid.\nDpr 2,3-Diaminopropionic acid.\nEtGly N-Ethylglycine.\nEtAsn N-Ethylasparagine.\nHyl Hydroxylysine.\naHyl allo-Hydroxylysine.\n3Hyp 3-Hydroxyproline.\n4Hyp 4-Hydroxyproline.\nIde Isodesmosine.\naIle allo-Isoleucine.\nMeGly N-Methylglycine, sarcosine.\nMeIle N-Methylisoleucine.\nMeLys 6-N-Methyllysine.\nMeVal N-Methylvaline.\nNva Norvaline.\nNle Norleucine.\nOrn Ornithine.","path":["Title 37—Patents, Trademarks, and Copyrights","CHAPTER I—UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE","SUBCHAPTER A—GENERAL","PART 1—RULES OF PRACTICE IN PATENT CASES","Subpart G—Biotechnology Invention Disclosures"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-37.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:25:45Z","sha256":"8d55a7bb58af2a614a312f5ecd9f55e53dfd23785e38d19af49e0e8029a26f5f","source_id":"us-cfr","stale":true,"prev":"us/37-cfr-appendix-c-to-subpart-g-of-part-1","next":"us/37-cfr-appendix-e-to-subpart-g-of-part-1"},"notice":"GroundRules: Original legal text. Not legal advice."}